Work

Frontline Nilotinib Versus Dasatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Propensity Score Analysis Based on Agenzia Italiana del Farmaco Monitoring Registries

Year: 2025

Type: article

Study design: Observational Study

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2026.04.015

Authors: Massimo Breccia, Pier Paolo Olimpieri, Fabrizio Pane, Simone Celant, Alessandra Iurlo, Valentina Summa, Paolo Corradini, Pier Luigi Zinzani, Pierluigi Russo

Institutions: Italian Medicines Agency, Federico II University Hospital, University of Naples Federico II, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Bologna

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417021518

FWCI:

Cites: 14

Cited by:

Related to: